| 摘要 |
The present invention includes novel compounds and methods of treating a disease or disorder by antagonizing Bcl-2 family proteins, particularly compounds of Formula (I)or a pharmaceutically acceptable salt thereof, as well as methods of treating a disease, disorder, or syndrome associated with Bcl-2 inhibition, particularly hyperproliferative diseases. The present invention also includes pharmaceutical compositions including compounds of formula (I) and pharmaceutically acceptable salts thereof. |
